Block & Leviton LLP Investigates Chemed Corporation for Possible Violations of the Federal Securities Laws

May 03, 2013, 14:54 ET from Block & Leviton LLP

BOSTON, May 3, 2013 /PRNewswire/ -- Block & Leviton LLP (, a Boston-based law firm representing investors nationwide, is investigating possible securities law violations by Chemed Corporation ("Chemed" or the "Company") (NYSE:  CHE) following the U.S. Department of Justice's ("DOJ") announcement that Chemed's Vitas Hospice units ("Vita") knowingly overbilled the Government's Medicare program.   

More specifically, the DOJ complaint alleges that Chemed and Vitas (collective, the "companies") knowingly submitted, or caused the submission of, false claims to Medicare for crisis care services that were not necessary, not actually provided, or not performed in accordance with Medicare requirements.   According to the DOJ, the companies set goals for the number of crisis care days that were to be billed to Medicare.   The companies also allegedly used aggressive marketing tactics and pressured staff to increase the numbers of crisis care claims submitted to Medicare, without regard to whether the services were appropriate or were actually being provided.  In addition, the DOJ alleges that the companies knowingly submitted, or caused the submission of, false claims for hospice care for patients who were not terminally ill.   The companies paid bonuses to staff based on the number of patients enrolled in the program and based on patients who were admitted for longer lengths of stay, and took adverse employment actions against marketing representatives who did not meet monthly hospice admissions goals.  

As a result of the conduct alleged in the DOJ complaint, the government contends that the companies violated the False Claims Act and misspent tens of millions of taxpayer dollars from the Medicare program.

Block & Leviton's investigation seeks to determine, among other things, whether Chemed or its officers and directors violated the federal securities laws by artificially and materially inflating its financial results.  If you purchased Chemed stock between May 2, 2008 through May 2, 2013 and have any information relevant to this investigation, or have questions about your legal rights, please contact attorney Steven P. Harte of Block & Leviton LLP at (617) 398-5600 or email him at

Block & Leviton is a Boston-based law firm representing investors for violations of securities laws.  The firm's lawyers have collectively been prosecuting securities cases on behalf of investors for over 50 years.

This notice may constitute attorney advertising.



Steven Harte, Esq.

(617) 398-5600

SOURCE Block & Leviton LLP